Home / Health / CAR T-cell Therapy: A New Hope for Stiff-Person Syndrome
CAR T-cell Therapy: A New Hope for Stiff-Person Syndrome
2 Jun
Summary
- A CAR T-cell therapy, usually for cancer, is now treating stiff-person syndrome.
- The Celine Dion Foundation funded research leading to this breakthrough.
- Therapy shows a 46% improvement, with patients walking without aids.
Researchers have successfully adapted CAR T-cell therapy, a treatment typically used for cancer, to address stiff-person syndrome (SPS). This innovative approach involves using a patient's own T-cells to combat the autoimmune disease. The therapy aims to deplete problematic B-cells, allowing healthy ones to return and essentially reset the immune system for a potentially long-lasting remission.
This critical research has been bolstered by significant funding from the Celine Dion Foundation. Early results from clinical trials are highly encouraging, with reports indicating substantial improvements in patients' mobility and overall health. Dr. Amanda Piquet noted a 46% improvement in participants, with some no longer requiring walking aids.
While long-term durability studies are ongoing, the initial outcomes suggest a revolutionary path forward for SPS treatment. Tara Zier, who founded the Stiff Person Syndrome Research Foundation, highlighted the profound impact of such advancements, emphasizing the vital need for hope among those affected by the condition.
